vs

Side-by-side financial comparison of APPFOLIO INC (APPF) and MADRIGAL PHARMACEUTICALS, INC. (MDGL). Click either name above to swap in a different company.

MADRIGAL PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($321.1M vs $262.2M, roughly 1.2× APPFOLIO INC). APPFOLIO INC runs the higher net margin — 16.2% vs -18.2%, a 34.4% gap on every dollar of revenue. On growth, MADRIGAL PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (210.8% vs 20.4%).

AppFolio, Inc. is an American company founded in 2006 that offers software-as-a-service (SaaS) applications and services to the real estate industry.

Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

APPF vs MDGL — Head-to-Head

Bigger by revenue
MDGL
MDGL
1.2× larger
MDGL
$321.1M
$262.2M
APPF
Growing faster (revenue YoY)
MDGL
MDGL
+190.3% gap
MDGL
210.8%
20.4%
APPF
Higher net margin
APPF
APPF
34.4% more per $
APPF
16.2%
-18.2%
MDGL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
APPF
APPF
MDGL
MDGL
Revenue
$262.2M
$321.1M
Net Profit
$42.4M
$-58.6M
Gross Margin
Operating Margin
19.4%
-18.6%
Net Margin
16.2%
-18.2%
Revenue YoY
20.4%
210.8%
Net Profit YoY
35.2%
1.4%
EPS (diluted)
$1.18
$-2.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APPF
APPF
MDGL
MDGL
Q1 26
$262.2M
Q4 25
$248.2M
$321.1M
Q3 25
$249.4M
$287.3M
Q2 25
$235.6M
$212.8M
Q1 25
$217.7M
$137.3M
Q4 24
$203.7M
$103.3M
Q3 24
$205.7M
$62.2M
Q2 24
$197.4M
Net Profit
APPF
APPF
MDGL
MDGL
Q1 26
$42.4M
Q4 25
$39.9M
$-58.6M
Q3 25
$33.6M
$-114.2M
Q2 25
$36.0M
$-42.3M
Q1 25
$31.4M
$-73.2M
Q4 24
$102.7M
$-59.4M
Q3 24
$33.0M
$-107.0M
Q2 24
$29.7M
Gross Margin
APPF
APPF
MDGL
MDGL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
96.7%
Q4 24
Q3 24
Q2 24
Operating Margin
APPF
APPF
MDGL
MDGL
Q1 26
19.4%
Q4 25
17.6%
-18.6%
Q3 25
14.1%
-39.7%
Q2 25
17.2%
-22.2%
Q1 25
15.5%
-57.8%
Q4 24
11.3%
-64.8%
Q3 24
20.7%
-187.1%
Q2 24
18.3%
Net Margin
APPF
APPF
MDGL
MDGL
Q1 26
16.2%
Q4 25
16.1%
-18.2%
Q3 25
13.5%
-39.8%
Q2 25
15.3%
-19.9%
Q1 25
14.4%
-53.4%
Q4 24
50.4%
-57.5%
Q3 24
16.0%
-172.0%
Q2 24
15.0%
EPS (diluted)
APPF
APPF
MDGL
MDGL
Q1 26
$1.18
Q4 25
$1.10
$-2.55
Q3 25
$0.93
$-5.08
Q2 25
$0.99
$-1.90
Q1 25
$0.86
$-3.32
Q4 24
$2.79
$-2.50
Q3 24
$0.90
$-4.92
Q2 24
$0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APPF
APPF
MDGL
MDGL
Cash + ST InvestmentsLiquidity on hand
$147.4M
$198.7M
Total DebtLower is stronger
$339.9M
Stockholders' EquityBook value
$470.2M
$602.7M
Total Assets
$580.6M
$1.3B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APPF
APPF
MDGL
MDGL
Q1 26
$147.4M
Q4 25
$107.0M
$198.7M
Q3 25
$76.1M
$295.7M
Q2 25
$73.5M
$186.2M
Q1 25
$56.9M
$183.6M
Q4 24
$42.5M
$100.0M
Q3 24
$62.4M
$232.7M
Q2 24
$59.6M
Total Debt
APPF
APPF
MDGL
MDGL
Q1 26
Q4 25
$339.9M
Q3 25
$339.8M
Q2 25
$118.4M
Q1 25
$118.0M
Q4 24
$117.6M
Q3 24
$117.1M
Q2 24
Stockholders' Equity
APPF
APPF
MDGL
MDGL
Q1 26
$470.2M
Q4 25
$542.6M
$602.7M
Q3 25
$498.9M
$625.7M
Q2 25
$455.6M
$696.0M
Q1 25
$462.1M
$710.6M
Q4 24
$519.3M
$754.4M
Q3 24
$412.8M
$777.2M
Q2 24
$371.4M
Total Assets
APPF
APPF
MDGL
MDGL
Q1 26
$580.6M
Q4 25
$689.0M
$1.3B
Q3 25
$640.5M
$1.4B
Q2 25
$567.4M
$1.0B
Q1 25
$564.7M
$996.6M
Q4 24
$626.7M
$1.0B
Q3 24
$523.3M
$1.1B
Q2 24
$479.3M
Debt / Equity
APPF
APPF
MDGL
MDGL
Q1 26
Q4 25
0.56×
Q3 25
0.54×
Q2 25
0.17×
Q1 25
0.17×
Q4 24
0.16×
Q3 24
0.15×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APPF
APPF
MDGL
MDGL
Operating Cash FlowLast quarter
$34.3M
$-133.5M
Free Cash FlowOCF − Capex
$-133.8M
FCF MarginFCF / Revenue
-41.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
0.81×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APPF
APPF
MDGL
MDGL
Q1 26
$34.3M
Q4 25
$65.0M
$-133.5M
Q3 25
$86.0M
$79.8M
Q2 25
$52.6M
$-47.1M
Q1 25
$38.5M
$-88.9M
Q4 24
$36.6M
$-104.5M
Q3 24
$57.8M
$-67.0M
Q2 24
$50.9M
Free Cash Flow
APPF
APPF
MDGL
MDGL
Q1 26
Q4 25
$63.7M
$-133.8M
Q3 25
$84.7M
$79.0M
Q2 25
$52.4M
Q1 25
$38.2M
Q4 24
$36.4M
$-104.7M
Q3 24
$57.4M
$-67.8M
Q2 24
$50.8M
FCF Margin
APPF
APPF
MDGL
MDGL
Q1 26
Q4 25
25.7%
-41.7%
Q3 25
34.0%
27.5%
Q2 25
22.2%
Q1 25
17.6%
Q4 24
17.9%
-101.3%
Q3 24
27.9%
-109.0%
Q2 24
25.8%
Capex Intensity
APPF
APPF
MDGL
MDGL
Q1 26
Q4 25
0.5%
0.1%
Q3 25
0.5%
0.3%
Q2 25
0.1%
0.0%
Q1 25
0.1%
0.0%
Q4 24
0.1%
0.2%
Q3 24
0.2%
1.3%
Q2 24
0.0%
Cash Conversion
APPF
APPF
MDGL
MDGL
Q1 26
0.81×
Q4 25
1.63×
Q3 25
2.56×
Q2 25
1.46×
Q1 25
1.23×
Q4 24
0.36×
Q3 24
1.75×
Q2 24
1.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APPF
APPF

Value Added Services$164.7M63%
Subscription Services$58.2M22%
Other$39.3M15%

MDGL
MDGL

Rebates Customer Fees Credits Co Pay Assistance And Other$208.5M65%
Other$76.0M24%
Chargebacks Discounts For Prompt Pay And Other Allowances$36.6M11%

Related Comparisons